supported by PID2020-120497RB-I00 MCIU/AEI/https://doi.org/10.13039/501100011033,BFU2017-90043-P MCINN/AEI/https://doi.org/10.13039/501100011033/;by FEDER“Una manera de hacer Europa”(MA and TA),Proyecto Intramural IdisNa 2022(MA),Fundación para la Investigación Médica Aplicada(FIMA)Proyectos I+D,2017(TA)and Fundación Occident and DalecandELA Association(MA);supported by República de Panamá,Programa de Becas IFARHU-SENACYT(reference number 270-2018-922),NP by AC FIMA pre-doctoral fellowship.
Main text The disruption of protein folding homeostasis in motoneurons(MNs)and the accumulation of protein aggregates are some of the main molecular hallmarks of amyotrophic lateral sclerosis(ALS).Evidence from sporad...
supported by Macao Science and Technology Development Fund(0061/2021/A2);Shenzhen Science and Technology Innovation Commission(EF026/ICMS-SHX/2022/SZSTIC).
Amyotrophic lateral sclerosis(ALS)is a fatal neurodegenerative disease characterized by progressive loss of motor neurons,resulting in global health burden and limited post-diagnosis life expectancy.Although primarily...
NIBIB(R01 EB023776),NIA(R01AG071787),NHLBI(R01 HL139605),Open Philanthropy,Silicon Valley Community Foundation,Foster Foundation,San Francisco Foundation,Georges’Harik Foundation,and Donors’Trust grants to IC.
Background: Amyotrophic lateral sclerosis (ALS) is characterized by a progressive loss of motor neurons (MNs), leading to paralysis, respiratory failure and death within 2-5 years of diagnosis. The exact mechanisms of...
supported by grants from the National Natural Science Foundation of China(81873784,82071426 and 81901298);Clinical Cohort Construction Program of Peking University Third Hospital(BYSYDL2019002).
Currently,there is no effective treatment for amyotrophic lateral sclerosis(ALS),despite the limited efficacy of riluzole[1]and edaravone[2].SOD1(coding for the Cu/Zn superoxide dismutase)is the second most frequent g...
This research was supported by the Brain Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Science and ICT(2017M3C7A102536521 and 2018R1A5A202596413).
Background:MicroRNAs(miRNAs)are endogenous non-coding RNAS that regulate gene expression at the post-transcriptional level and are key modulators in neurodegenerative diseases.Overexpressed miRNAs play an important ro...
This work was supported by the National Natural Science Foundation of China under Grant 81030019;Peking University-Ulm University Union Foundation under Grant PKU2017ZC001-2;the Natural Science Foundation of Beijing Municipality under Grant 7102161;the National Clinical Key Program of China.
Background:SOD1 mutations are the most common cause of amyotrophic lateral sclerosis(ALS)in non-Caucasian patients.Detailed natural history profiles of SOD1-mutant patients will be beneficial for the strategy and inte...
In the original publication of this article[1],a numerical value in the sentence“The mean(SD)AAO was 43.92 years(9.24)for all subjects,with a significant difference between patients carrying mutations in exon 2(n=24,...
This study was supported in part by a Chicago Biomedical Consortium(CBC)postdoctoral fellowship grant(Award#085740)to RG at the University of Illinois in Chicago.
Background:Amyotrophic lateral sclerosis(ALS)is a disease characterized by a progressive degeneration of motor neurons leading to paralysis.Our previous MRI diffusion tensor imaging studies detected early white matter...
This work was supported by funding from the National Natural Sciences Foundation of China(NSFC 81430021 and 81370470);the Program for Liaoning Innovative Research Team in University(LT2015009);Liaoning Science and Technology Project(2015225008).
Background:Neuron-microglia communication plays a crucial role in the motor neurons(MNs)death in amyotrophic lateral sclerosis(ALS).Neurons can express chemokine(C-X3-C motif)ligand 1(CX3CL1),which mediates microglial...